本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lexeo Therapeutics

3.21
-0.1000-3.02%
盘后:3.210.00000.00%19:30 EDT
成交量:254.61万
成交额:809.38万
市值:2.63亿
市盈率:-2.80
高:3.28
开:3.27
低:3.11
收:3.31
52周最高:10.99
52周最低:2.98
股本:8,204.63万
流通股本:5,122.95万
量比:1.26
换手率:4.97%
股息:- -
股息率:- -
每股收益(TTM):-1.1457
每股收益(LYR):-1.8634
净资产收益率:-46.76%
总资产收益率:-27.59%
市净率:1.12
市盈率(LYR):-1.72

数据加载中...

2026/09/29

重要事件披露

Form 8-K - Current report
2026/09/22

重要事件披露

Form 8-K - Current report
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities